User profiles for Natalie E. Stevens

Natalie Emilia Stevens

South Australian Health and Medical Research Institute
Verified email at sahmri.com
Cited by 594

Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes

NE Stevens, MJ Chapman, CK Fraser, TR Kuchel… - Scientific reports, 2017 - nature.com
Sepsis remains a significant health burden and a major clinical need exists for therapeutics
to dampen the excessive and uncontrolled immune activation. Nuclear protein high mobility …

[PDF][PDF] The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota

…, SC Benson, DJ Tumes, A Sribnaia, NE Stevens… - Cell Reports …, 2021 - cell.com
Immune agonist antibodies (IAAs) are promising immunotherapies that target co-stimulatory
receptors to induce potent anti-tumor immune responses, particularly when combined with …

[PDF][PDF] A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines

…, TS Norton, C McCafferty, SJ Blake, NE Stevens… - Cell Reports …, 2023 - cell.com
Identifying the molecular mechanisms that promote optimal immune responses to coronavirus
disease 2019 (COVID-19) vaccination is critical for future rational vaccine design. Here, …

[HTML][HTML] Skin barrier and autoimmunity—mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin

NE Stevens, AJ Cowin, Z Kopecki - Frontiers in Immunology, 2019 - frontiersin.org
One of the most important functions of the skin besides regulating internal body temperature
includes formation of the barrier between the organism and the external environment, hence …

Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial

…, KP Perrett, LF Pittet, R Rudraraju, NE Stevens… - …, 2024 - thelancet.com
Background The COVID-19 pandemic led to the rapid development and deployment of
several highly effective vaccines against SARS-CoV-2. Recent studies suggest that these …

No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines

NE Stevens, FJ Ryan, NL Messina… - The Journal of …, 2023 - Am Soc Clin Investig
… © 2023 Stevens et al. This work is licensed under the Creative Commons Attribution 4.0
International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0 …

CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1

N Lakhan, NE Stevens, KR Diener… - Journal of immunological …, 2016 - Elsevier
Adjuvants are used to enhance the immune response against specific antigens for the production
of antibodies, with the choice of adjuvant most critical for poorly immunogenic and self-…

Flightless I alters the inflammatory response and autoantibody profile in an OVA-induced atopic dermatitis skin-like disease

Z Kopecki, NE Stevens, HT Chong, GN Yang… - Frontiers in …, 2018 - frontiersin.org
Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease characterized by
excessive inflammation and disrupted skin barrier function. Although the etiology of AD is not …

Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice

NE Stevens, M van Wolfswinkel, W Bao, FJ Ryan… - Vaccine, 2022 - Elsevier
… Author links open overlay panel Natalie E. Stevens a , Marjolein van Wolfswinkel a b 1 ,
Winnie Bao c , Feargal J. Ryan a , Byron Brook d , Nelly Amenyogbe d e , Helen S. Marshall f g , …

Recombinant leucine-rich repeat flightless-interacting protein-1 improves healing of acute wounds through its effects on proliferation inflammation and collagen …

Z Kopecki, NE Stevens, GN Yang, E Melville… - International Journal of …, 2018 - mdpi.com
Wound healing is an increasing clinical problem involving substantial morbidity, mortality,
and rising health care costs. Leucine-rich repeat flightless-interacting protein-1 (LRRFIP-1) …